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Abstract 
 
The present study examined the prevalence of drug driving in a sample of Queensland drivers. 
Oral fluid samples were collected from 276 drivers who volunteered to participate at Random 
Breath Testing (RBT) sites in the area of the Gold Coast, Queensland. Illicit substances tested 
for included cannabis (delta 9 tetrahydrocannibinol [THC]), ecstasy (MDMA), amphetamines 
and cocaine. Drivers also completed a self-report questionnaire regarding their drug-related 
driving behaviour. Oral fluid samples from 9 participants (3.3%) were found to be positive for at 
least one illicit substance. The most common drugs detected in oral fluid were cannabis (n = 6) 
followed by amphetamines (n = 3). A key finding was that cannabis was also confirmed as the 
most common self-reported drug combined with driving and that individuals who tested positive 
to any drug through oral fluid analysis were also more likely to report the highest frequency of 
drug driving. This research provides preliminary evidence that drug driving may be relatively 
prevalent on Queensland roads. This paper will further outline the major findings of the study 
and present possible directions for future drug driving research.   
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INTRODUCTION 
 
In recent times, drug driving has become an escalating issue in road safety. An increasing 
amount of research has focused on ascertaining the incidences of drug driving and the impact on 
road safety.  For example, a considerable body of literature is accumulating that has focused on 
detecting the presence of drugs in body fluids of those who have been involved in a crash (de 
Rio et al. 2002; Drummer et al. 2003). It has been shown that drug use among this group is 
anywhere between 8.8% and 39.6% for those who have been fatally injured (Del Rio et al. 2002; 
Drummer et al. 2003; Gjerde, Beylich and Morland 1993; Mura et al. 2006; Seymour and Oliver 
1999; Swann, Boorman and Papafotiou 2004). Historically, the predominant illicit drug found in 
the systems of the majority of such drivers is cannabis. This trend of cannabis use is also 
prevalent among crash-involved, but non-fatally injured drug drivers, as the proportion of illicit 
substances (including the predominant substance of cannabis), among this group has also been 
found to be between 2.7% and 41.3% (Athanaselis et al. 1999; Longo et al. 2000; Soderstrom et 
al. 1995; Stoduto et al. 1993; Waller et al. 1997).  
 
Additionally from this data, research has found a strong association between drug driving and 
culpability, with accident risk for illicit drug drivers estimated to be as high as a driver with a 
blood alcohol content of 0.1 to 0.15% (Drummer et al. 2003). However, extrapolating further 
from this data for an indication of the extent of drug driving among the greater driving 
population is a difficult task (Drummer et al. 2004), as drivers judged at fault in an accident are 
naturally more likely to be drug tested, and therefore also more likely to appear in official 
statistics of this nature. Again, this provides challenges in capturing an accurate community-
wide picture of drug driving. 
 
With a view towards the illicit drug use of drivers in general, beyond those involved in crashes, 
there is less population-wide data readily available. Historically, the prevailing view of drug 
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driving in the community is that it is relatively uncommon amongst the general driving 
population (Kelly, Darke and Ross 2004). However, a growing body of research has indicated 
that the self-reported prevalence of drug driving varies markedly between 2% and 90% of 
respondents, although most research suggests between 3% and 10% (Kelly, Darke and Ross 
2004). Despite this, among some subcultures, researchers have indicated the percentage of drug 
driving may be much higher. For example, amphetamine use among some samples has been 
found to be 62% (Akram 1997), while drug driving among a sample of cannabis users has been 
reported to be approximately 82% (Terry and Wright 2005). Research has generally indicated 
that the most common drug combined with driving is usually cannabis (Davey, Leal and 
Freeman 2007; Drummer et al. 2003; Terry and Wright 2005), which may in part be associated 
with perceptions that cannabis does not have a negative impact on driving performance (Terry 
and Wright 2005). However, it is also noted that amphetamine use and driving are also 
frequently combined among some sub-groups of motorists (Albery et al. 2000; Darke, Kelly and 
Ross 2004; Davey, Leal and Freeman 2007).   
 
Within Australia, a large contemporary questionnaire-based study of 6801 drivers revealed that 
12.3% of the sample reported driving within 3 hours of using cannabis in the past 12 months 
(Mallick et al. 2007).  Smaller Australian studies that have focused on young drivers (e.g., 
university students) have also revealed similar results, with between 8.2% and 15% of motorists 
reporting driving after consuming some form of illicit substance on a yearly basis (Armstrong, 
Wills and Watson 2005; Davey, Davey and Obst 2005). A three-year study of police traffic 
detainees in three Australian states found that 70% tested positive to one drug and approximately 
one third (e.g., 38%) tested positive to more than one drug (Poyser et al., 2002). A similar 
Australian study that examined motorists involved in traffic accidents revealed that 16.4% of 
injured drivers tested positive to tetrahydrocannabinol (THC) and 6.9% tested positive to 
amphetamines (Caldicott et al. 2007). 
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Recently, the development and use of oral fluid drug testing methods for roadside use has 
provided an additional source of information to determine the prevalence of drug driving, as 
sample collection is relatively simple and non-invasive (Dolan, Rouen and Kimber 2004; Speedy 
et al. 2004). Research concerning body fluid samples has traditionally focused on samples of 
drivers alleged to have been driving under the influence of drugs and/or those involved in 
vehicle crashes.  However, in addition to this source, research has commenced focusing on 
random roadside drug testing to provide another estimate of the extent of drug driving on public 
roads, including those who are not involved in crashes. An earlier oral fluid study reported 4.7% 
of drivers from a random sample of non-crash drivers were confirmed positive to the presence of 
drugs in the United Kingdom (Buttress et al. 2004), while a German study identified illicit 
substances in 16.8% of a sample of motorists (Wylie et al. 2005).  
 
One of the first Australian studies was implemented by the Victorian police force who recorded 
a drug driving prevalence rate of one driver in 40 (2.4%) for cannabis, ecstasy and 
amphetamines, which is more than double the positive alcohol-driving rate (Drummer et al. 
2007). In addition, Davey, Leal and Freeman (2007) also examined the prevalence of drug 
driving in Townsville (Queensland) and reported 3.5% of the sample tested positive to one illicit 
substance, which was again greater than the detection of drink drivers during the same testing 
period (0.8%).  As noted previously, an even larger detection rate was reported in a three-year 
study of police traffic detainees in three Australian states, as the researchers reported that 70% 
tested positive to one drug and approximately one third (38%) tested positive to more than one 
drug (Poyser et al., 2002). While these studies are not necessarily random, the  findings 
nonetheless indicate that drug driving presents as a serious threat to road safety, and additionally 
prompts the need for further research to determine the prevalence of non-crash drug driving rates 
in Australia, especially for drugs such as cannabis, amphetamines, ecstasy and cocaine.   
 
As a result, the major objectives of this study were to: 
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• Measure the prevalence of drug driving among a sample of Queensland drivers in the 
city of the Gold Coast; and 
• Investigate the self-reported frequency of general motorists’ involvement in drug driving 
behaviour. 
  
METHOD 
Participants, Materials and Procedure 
Drivers stopped at Random Breath Testing operations across a large area of the Gold Coast, 
Queensland, were approached and asked by operational police to participate in the drug driving 
research, which was positioned on average 100 metres further down the road. Participation was 
voluntary and involved completing a self-report questionnaire (in the researchers’ presence) 
regarding recent illicit drug use and drug driving in the previous 12 months, and providing a 
sample of oral fluid that could later be screened for the presence of drugs. The procedure took 
approximately 10-20 minutes to complete and drivers received a one-off payment of $20 cash to 
reimburse them for their time. Data was collected over a two month period, on ten separate 
occasions on Friday and Saturday nights, usually between the hours of 5pm and 1am1.   
 
A 12 item self-report questionnaire was designed to assess a variety of demographic data (e.g., 
gender, age, years driving) as well as self-reported drug use and the frequency of drug driving 
behaviour. Participants responded to questions that investigated the most recent use of marijuana 
/ cannabis (within four hours, within the last 24 hours, within the last week, within the last 
month, within the last year, more than a year ago, have never used). This question was repeated 
for meth / amphetamines (such as speed, oil, base, and crystal), ecstasy, heroin and cocaine. 
Participants were also required to indicate how often in the previous 12 months they had 
operated a motor vehicle (including a motorcycle) within four hours of using marijuana / 
                                                 
1 Workplace health and safety requirements resulted in the current roadside project only being implemented 
with the presence of the Queensland Police Service.  RBT operations were deemed to be the most compatible 
roadside activity and thus drug testing procedures corresponded within traditional RBT operational hours e.g., 
5pm – 1am.   
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cannabis (every day, more than once a week, about once a week, 11 – 20 times, 3 – 10 times, 
once or twice, never). Once again, this question was repeated for meth / amphetamines (such as 
speed, oil, base, and crystal), ecstasy, heroin and cocaine. The majority of the data was 
descriptive and/or categorical, and recorded as percentage frequencies, and thus, chi-square tests 
were performed where appropriate.   
 
In addition, oral fluid samples were collected, stored and screened off-site at a later date using 
the Cozart® RapiScan oral fluid drug test device. Participants provided a sample of oral fluid 
that was collected from inside their mouth via a pad held either under their tongue or beside the 
inside of their cheek. The five-panel cannabis and single-panel methamphetamine / MDMA test 
cartridges were used (i.e. each sample was screened twice). Each Cozart® RapiScan kit 
consisted of a collector, transport tube containing buffer solution, separator filter tube, pipette 
and test cartridge. The five-panel cannabis cartridge detected the presence of benzodiazepines, 
amphetamines, cannabis (THC), and cocaine, while the single-panel methamphetamine / 
MDMA cartridge detected the presence of methamphetamine and MDMA (ecstasy). There was 
no subjectivity in the interpretation of results as the Cozart® RapiScan testing instrument 
displayed and printed results. 
 
RESULTS 
Sample and Response Rate 
A total of 276 motorists in the Gold Coast area volunteered to participate in the study. As a 
result of resourcing restrictions and the referral procedure from the Police RBT location, it was 
difficult to acquire an accurate measurement of the proportion of responses over the entire data 
collection stage2.  
 
                                                 
2 The procedure usually consisted of RBT operational police officers informing motorists (who had given a 
breath sample) that they had the opportunity to participate in an anonymous research drug driving project 
being conducted approximately 100 metres down the road.   
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More than half the participants were male (n = 183, 66.3%).  Participants’ ages were between 17 
and 68 years (mean age = 28.07 years, SD = 11.03). There were 8 participants that did not 
indicate their gender. On average, participants had been driving for 11.03 years (SD = 10.03). 
The majority of the participants reported driving daily (n = 241, 87.3%) followed by three to 
five times per week (n = 27, 9.8%).  
 
Prevalence of Positive Drug Tests 
Drug screening tests revealed that oral fluid samples from 9 drivers (3.3% of the total 
sample) contained at least one illicit substance. Table 1 outlines the results by drug group 
detected and gender of the driver. As depicted in Table 1, the most common drug detected 
was cannabis followed by amphetamines, while samples from 4 participants were 
consistent with polydrug use.   
 
The 9 drivers who provided samples that were confirmed positive for at least one illicit 
substance were male (n = 9, 100%), and aged between 17 and 29 (mean = 23.1 years, SD = 
3.85). In addition, this group had less driving experience than the sample average (mean = 6.6 
years, SD = 4.37). However, frequency of driving was similar for the two groups, with all 
participants that were screened positive for any illicit drug reported driving daily (n = 9, 100%). 
 
INSERT TABLE 1 HERE 
 
Self-reported Prevalence of Drug Driving 
In addition to the analysis of body fluids, an investigation was also undertaken to examine 
participants’ self-reported drug use and drug driving behaviours. Firstly for drug use, the most 
commonly consumed drug was cannabis, with 28.4% reporting the use of the substance within 
the last year, and 9.1% of this group reporting usage in the last week. Frequency of use for 
ecstasy and amphetamines was similar with 18.8% reporting the use of ecstasy within the last 
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year, and 4.3% reporting use in the last week, whilst 16.7% reported using amphetamines within 
the last year and 4.0 % used the substance in the last week. Finally, 8.7% reported using cocaine 
and 0.4% of the sample reported using heroin during the last year. Chi-square analysis revealed 
no significant gender differences for reporting regular use of cannabis, while small cells sizes 
precluded analysis of the other substances. 
 
For drug driving, similar to the above findings, the most common substance combined with 
driving was cannabis followed by ecstasy (see Table 2). More specifically, 4.7% reported using 
cannabis and 2.2% reported using ecstasy before driving at least once a week. Less than 1.5% 
reported using amphetamines, cocaine and heroin before driving at least once a week. Finally, 
examination of the self-reported drug use for the 9 individuals who tested positive to the 
presence of drugs revealed that drug driving was most common among these individuals, 
although the small sample size limits meaningful comparisons.  Nonetheless, 7 (77.8%) reported 
driving within four hours of using at least one of the drugs outlined on the questionnaire.  
 
INSERT TABLE 2 HERE 
 
DISCUSSION 
This paper aimed to report on an investigation into the prevalence of drug driving in the 
Queensland tourist city of the Gold Coast. Specifically, the study focused on measuring the self-
reported prevalence of drug driving in the area, as well as the major drug types that may be used 
when driving.   
 
Prevalence of Positive Drug Tests 
The first major finding of the study was that 3.3% (n=9) of the oral fluid samples provided a 
positive illicit drug reading. The finding is consistent with the small amount of preliminary 
Australian research that has focused on randomly drug testing motorists through oral fluid 
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analysis (Davey et al. 2007; Drummer et al. 2007). In addition, the detection rate for drug drivers 
(in the current case) appears higher than the corresponding detection rates for drink drivers in 
Queensland (Davey et al. 2007; Freeman and Watson 2006). However, it is noted that these 
findings are only preliminary and the data sample for the current study focuses specifically on a 
large tourist city. Nevertheless, the results suggest that a notable proportion of motorists drive 
under the influence of drugs, rather than alcohol, in the early hours of the morning.   
 
In regards to the characteristics of the drivers most likely to test positive to illicit substances, the 
individuals were male and under 29 years of age. The results are again consistent with previous 
random roadside drug testing research in Queensland (Davey, Leal and Freeman 2007) as well 
as general drug research that has consistently indicated that males are more likely to consume 
illicit substances than females (Begg and Langley 2004; Neale 2004), and in particular, engage 
in poly drug use (Milani et al. 2004).   
 
In regards to the identified substances, four types of drugs were detected: (i) cannabis (delta 9 
THC), (ii) amphetamines (iii) ecstasy and (iv) cocaine. Firstly, cannabis was the most common 
illicit substance identified in the current sample. This finding is consistent with self-report 
research that indicates cannabis is also most often combined drug with driving (Davey et al. 
2007; Drummer et al. 2003; Terry and Wright 2005), although it is noted that drug detection 
rates may prove to vary with specific locations. Additionally, it is noted that the sample size as 
well as the differences identified between the different drug types was relatively small, and thus 
the findings need to be replicated with larger sample sizes.   
 
Self-reported Prevalence of Drug Driving 
Examination of the self-reported data revealed that cannabis was also the most frequently 
consumed illicit substance, and not surprisingly, was also the most frequent drug to be used 
when driving. The findings again support previous research that has indicated cannabis is the 
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most prevalent drug associated with driving (Davey et al. 2007; Drummer et al. 2003; Seymour 
and Oliver 1999; Swann et al. 2004). Furthermore, individuals who tested positive to the drug 
testing process also reported the highest rate of drug driving. Importantly, these findings indicate 
that there appears to be some level of congruency between the self-reported and oral fluid data. 
Additionally, the findings also provide preliminary evidence that positive drug testing outcomes 
highlight individuals at risk of regularly engaging in drug driving, and to a lesser extent, provide 
support for the reliability of the self-report data (Davey et al. 2007).   
 
A number of methodological limitations associated with the study should be borne in mind when 
interpreting the findings. The results of the study are not necessarily generalisable, as the data 
was sampled from a specific tourist area of Queensland (e.g., Gold Coast), and it is likely that 
drug use (and therefore, drug driving trends) may vary by area due to factors associated with 
supply, demand and cost of the drugs. Further, although a wide age range was observed, the 
sample was skewed towards younger age groups (M = 28 years) and additionally, the sample size 
is quite small. Importantly, the sample of this study may prove to be representative of drivers at 
night on weekends, which may be a peak drug driving period. However, given that data was only 
collected between the hours of 5pm and 1am, it is possible that drug driving rates may increase or 
decrease further into the early hours of the morning, as well as during the day. Furthermore, the 
possibility of self-report and volunteer bias remains, and although the Queensland Police Service 
were not directly involved in the research project, it is possible that operational officers’ presence 
at the research site deterred some individuals from participating (specifically those under the 
influence of drugs). Additionally, it would have been ideal to have measured the number of 
motorists who were tested at the RBT sites during the study period so as to compare (and obtain a 
ratio) of drink drivers to drug drivers, and future research should include such an approach.   
 
Despite such limitations, this study has provided evidence that drug driving may be prevalent in 
some areas within Queensland, and thus, drug driving may currently present as a serious threat 
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to road safety. The recent introduction of the random roadside drug testing legislation in 
Queensland appears to be an important and necessary step in attempting to combat drug driving. 
Considering that previous research has indicated that perceptions of apprehension certainty are a 
key element in deterring both drink drivers (Piquero and Pogarsky 2002) and drug drivers 
(Davey, Davey and Obst 2005) from engaging in such offending behaviours, the implementation 
of the new detection method has the potential to impact on the prevalence of drug driving. In 
addition to determining the effectiveness of the countermeasure to apprehend offending 
motorists, it may prove beneficial for further research to examine motorists’ current perceptions 
regarding the likelihood of being detected for drug driving, and their corresponding beliefs about 
the effectiveness, and impact of saliva testing on offending rates. Such information would 
provide additional information regarding the most effective methods to implement and reinforce 
the deterrent element of random roadside drug testing. Taken together, further investigation into 
the prevalence, type, impact and prevention of drug driving can only assist with the development 
and implementation of effective countermeasures and supportive enforcement practices aimed at 
reducing the burden of drug driving on road safety.    
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Tables 
Table 1 
Number and Proportion of Participants Testing Positive by Drug Group 
 
 Total
3 
N = 276 
Males 
N = 183 
Females 
N = 85 
Cannabis (THC)   6 (2.2%)  6 (3.3%)  0 (0.0%) 
Amphetamines   3 (1.1%)  3 (1.6%)  0 (0.0%) 
Cocaine  2 (0.7%)  2 (1.1%)   0 (0.0%) 
Ecstasy (MDMA)  2 (0.7%)  2 (1.1%)  0 (0.0%) 
Total illicit substances4  13 (4.7%)  13 (7.1%)  0 (0.0%) 
 
Table 2 
Drug Driving Behaviour 
 
Cannabis Amphetamines Ecstasy Cocaine Heroin Drug Type     n %   n % n %   n %   n % 
Drug Driving 
 Every day 
 More than once week 
 About once a week 
 11 - 20 times 
 3 - 10 times 
 Once or twice 
 Never 
 
 
  6 
  4 
  3 
  3 
   5 
  15 
 238 
 
 (2.2) 
 (1.4) 
 (1.1) 
 (1.1) 
 (1.8) 
 (5.4) 
(86.2) 
 
 
 0 
 4 
 0 
 5 
 3 
 0 
 253 
 
 
 (0.0) 
 (1.4) 
 (0.0) 
 (1.8) 
 (1.1) 
 (3.6) 
(91.7) 
 
 
 1 
 1 
 4 
 4 
 3 
 16 
246 
 
(0.4) 
(0.4) 
(1.4) 
(1.4) 
(1.1) 
(5.8) 
(89.1) 
 
 0 
 0 
 2 
 2 
 2 
 12 
257 
 
 (0.0) 
 (0.0) 
 (0.7) 
 (0.7) 
 (0.7) 
 (4.3) 
(93.1) 
 
 1 
 0 
 0 
 0 
 0 
 1 
 273 
 
(0.4)
(0.0)
(0.0)
(0.0)
(0.0)
(0.4) 
(98.9)
 
 
 
 
 
 
 
 
 
 
 
 
 
_________________________________________________________________________ 
3 8 respondents did not provide their gender. 
4 4 respondents screened positive to more than one drug. 
